EPN2

EPN2 (epsin 2) is a specialized clathrin-mediated endocytic adaptor that selectively controls the internalization and degradation of specific signaling receptors rather than supporting bulk endocytosis (PMID:19666558). Acting redundantly with EPN1, EPN2 is required for Notch signaling activation during embryogenesis, as combined Epn1/Epn2 loss recapitulates global Notch impairment and abolishes Notch target gene expression while leaving housekeeping clathrin-mediated endocytosis intact (PMID:19666558). In endothelial cells, EPN2 restrains angiogenesis by mediating internalization and degradation of activated VEGFR2, since epsin loss elevates VEGFR2 and produces aberrant angiogenesis that is rescued by reducing VEGFR2 gene dosage (PMID:24311377); consistent with this anti-angiogenic role, EPN2 acts as a suppressor of endothelial tube formation downstream of miR-1224 (PMID:28717225). EPN2 likewise limits Wnt/β-catenin signaling: its long transcript isoform drives clathrin-dependent endocytic degradation of the Wnt receptor FZD7, and loss of this isoform sustains Wnt activation and promotes esophageal squamous cell carcinoma progression (PMID:42210380). In podocytes, epsins (Epn1/2/3) support cell adhesion and spreading upstream of a Cdc42–SRF–β1 integrin axis, with their loss causing albuminuria and foot process effacement (PMID:33051360).

1. 2009 High

   Established that epsins are not generic endocytic machinery but specialized adaptors dedicated to receptor signaling, answering whether EPN1/EPN2 have a selective in vivo function.

   Evidence Epn1/Epn2 double-knockout mice with Notch target gene analysis and endocytosis assays in derived cells

   PMID:19666558

   Open questions at the time

   • Does not resolve EPN2-specific contribution versus EPN1 redundancy
   • Direct biochemical link between EPN2 and Notch receptor/ligand internalization not shown
   • Molecular basis of cargo selectivity over bulk endocytosis unaddressed
2. 2013 High

   Identified a specific cargo for epsin-mediated degradation by showing epsins downregulate activated VEGFR2 to restrain angiogenesis, defining a mechanistic substrate beyond Notch.

   Evidence Endothelial-specific Epn1/Epn2 double-KO combined with Flk1 heterozygosity rescue; in vitro and in vivo angiogenesis assays

   PMID:24311377

   Open questions at the time

   • EPN2-specific role not separable from EPN1 in the double-KO
   • Direct EPN2-VEGFR2 physical interaction not biochemically defined
   • Mechanism distinguishing VEGFR2 from other endothelial receptors unknown
3. 2017 Medium

   Placed EPN2 within a regulatory circuit by showing it acts as a miR-1224-controlled suppressor of angiogenic tube formation, linking EPN2 expression level to endothelial behavior.

   Evidence miR-1224 modulation, EPN2 knockdown/overexpression, and tube formation assays in HUVECs with direct target validation

   PMID:28717225

   Open questions at the time

   • Single-lab study without reconstitution or structural data
   • Whether anti-angiogenic effect operates through VEGFR2 degradation not tested here
   • In vivo relevance of the miR-1224→EPN2 axis not established
4. 2020 Medium

   Extended epsin function to cytoskeletal/adhesion signaling by placing epsins upstream of a Cdc42-SRF-β1 integrin axis required for podocyte function.

   Evidence Podocyte-specific Epn1/2/3 triple-KO mice; albuminuria, adhesion/spreading assays, Cdc42 activation and β1 integrin expression analysis

   PMID:33051360

   Open questions at the time

   • EPN2 studied only within a triple-KO, so its individual contribution is unresolved
   • Single lab; mechanism connecting epsins to Cdc42 activation not defined
   • Whether the role depends on receptor endocytosis is unclear
5. 2026 Medium

   Defined isoform-level specificity by showing the EPN2 long transcript drives clathrin-dependent FZD7 degradation to limit Wnt/β-catenin signaling and tumor progression.

   Evidence RNA pull-down, RIP, RAP, splicing analysis, surface biotinylation, and EPN2 long-transcript overexpression in vitro and in vivo in ESCC models

   PMID:42210380

   Open questions at the time

   • Single lab; isoform specificity not yet independently replicated
   • Direct EPN2–FZD7 interaction interface not mapped
   • Functional difference between EPN2 transcript isoforms mechanistically undefined

• How EPN2 selects specific signaling receptors (Notch, VEGFR2, FZD7) for internalization while sparing bulk endocytosis, and how EPN2 is distinguished from EPN1/EPN3 at the molecular level, remains unresolved.
• No structural or biochemical map of EPN2 cargo recognition
• EPN2-specific (non-redundant) functions not isolated from paralogs
• Recruitment determinants distinguishing signaling cargo from bulk cargo unknown